Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis
Safa, G.; Martin, A.; Darrieux, L.
Journal of Clinical Rheumatology Practical Reports on Rheumatic and Musculoskeletal Diseases 17(7): 385-386
2011
ISSN/ISBN: 1536-7355
PMID: 21946468
DOI: 10.1097/rhu.0b013e31823262c3
Accession: 053108456
PDF emailed within 0-6 h: $19.90
Related References
Capkin, E.; Karkucak, M.; Yayli, S.ş; Aydin Çapkin, A.; Tosun, M. 2011: Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 17(5): 293-294Suh, H.Y.; Ahn, J.Y.; Park, M.Y.; Youn, J.I. 2018: Exacerbation of infliximab-induced paradoxical psoriasis after ustekinumab therapy Journal of Dermatology 45(3): 332-333
Alabed, I.B.; Qushmaq, K.A.; Khan, M.A. 2010: Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis Saudi Medical Journal 31(9): 1054-1056
Sakaura, H.; Hosono, N.; Mukai, Y.; Fujii, R.; Yoshikawa, H. 2006: Paraparesis due to exacerbation of preexisting spinal pseudoarthrosis following infliximab therapy for advanced ankylosing spondylitis Spine Journal: Official Journal of the North American Spine Society 6(3): 325-329
Ruwaard, J.; VAN DER Vlugt, E.R.; Wolbink, G. 2019: Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy Journal of Rheumatology 46(1): 117-118
Delle Sedie, A.; Bazzichi, L.; Bombardieri, S.; Riente, L. 2007: Psoriasis, erythema nodosum, and nummular eczema onset in an ankylosing spondylitis patient treated with infliximab Scandinavian Journal of Rheumatology 36(5): 403-404
Famenini, S.; Wu, J.J. 2013: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases Journal of Drugs in Dermatology: Jdd 12(8): 939-943
Sanli, H.; Ataman, S.; Akay, B.ü N.; Yilmaz, A.; Yildizlar, D.; Gürgey, E. 2007: Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy Journal of Drugs in Dermatology: Jdd 6(8): 834-836
Kwon, S.-R.; Jung, K.-H.; Lim, M.-J.; Son, M.-J.; Choi, B.H.; Park, S.-G.; Park, W. 2017: The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis Clinical and Experimental Rheumatology 35(5): 837-843
Bae, J.M.; Eun, S.H.; Kim, K.-J. 2020: Palmoplantar pustulosis secondary to anti-tumor necrosis factor therapy in a patient with ankylosing spondylitis Korean Journal of Internal Medicine 35(1): 254-255
Bodur, H.; Eser, F.; Konca, S.; Arikan, S. 2009: Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis Rheumatology International 29(4): 451-454
Akgül, Öz.ür.; Kılıç, G.; Kılıç, E.; Cüce, İs.; Özgöçmen, S. 2014: A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept Rheumatology International 34(3): 443-444
Aybay, C.; Ozel, S.; Aybay, C. 2006: Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis Rheumatology International 26(5): 473-480
Bouchra, A.; Benbouazza, K.; Hajjaj-Hassouni, N. 2009: Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy Clinical Rheumatology 28(Suppl 1): S53-S55
Ozçakar, L.; Ekiz, T.; Yalçın, S.üh.; Akıncı, A.şe. 2013: IgA nephropathy in an ankylosing spondylitis patient during infliximab therapy: chicken, egg or mother and child reunion? Acta Reumatologica Portuguesa 38(4): 310
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Garber, C.; Rosmarin, D.; Nguyen, B.; Goodarzi, M.; Shinagare, S.; Jessup, C.; Madani, A.; Au, S.-C.; Hasanain, A. 2017: Cutaneous mucinosis in a patient taking ustekinumab for palmoplantar psoriasis Dermatology Online Journal 23(3)
Santiago, T.ân.; Santiago, M.G.; Rovisco, J.ão.; Duarte, C.át.; Malcata, A.; da Silva, J.é A.ón.P. 2013: A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent? Clinical Rheumatology 32(12): 1819-1822
Tonini, A.; Zanframundo, S.; Panduri, S.; Marchetti, E.; Romanelli, M.; Chiricozzi, A. 2019: Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis Jaad Case Reports 5(6): 484-487
Watabe, D.; Amano, H. 2021: TNF-α inhibitor-induced paradoxical psoriasis and erythema nodosum in a patient with ankylosing spondylitis European Journal of Dermatology: Ejd 31(3): 412-413